ACE2 and Glucose intolerance: Patel et al. [48] showed that loss of angiotensin-converting enzyme (ACE2), a key pathogenic mechanism involved in the development of CVDs, resulted in decreased weight gain but increased glucose intolerance and EAT inflammation, including polarization of EAT resident macrophages into a pro-inflammatory phenotype in mice fed HFD.